Bovine Rhinotracheitis-Virus Diarrhea Vaccine

Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For use in healthy breeding cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR) and bovine virus diarrhea (BVD Type 1 and BVD Type 2) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. For use in calves vaccinated at four weeks of age, or older, as an aid in the prevention of hardjo-bovis kidney colonization, and as an aid in preventing urinary shedding and reproductive tract infection for 12 months. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure.

Dosage:  Administer 5 mL subcutaneously 2-4 weeks prior to breeding.  Revaccinate in 4-5 weeks. Revaccinate annually or as recommended by your veterinarian.

Safety Data Sheet

Manufacturer Information

SKU: GLARBVLHB Category: Brand: